Methods for cancer treatment using TAKI inhibitors

Details for Australian Patent Application No. 2007274055 (hide)

Owner AstraZeneca AB

Inventors Yu, Lihua; Byth, Kate; Palakurthi, Sangeetha; Zhang, Qi

Agent Davies Collison Cave

Pub. Number AU-A-2007274055

PCT Pub. Number WO2008/007072

Priority 60/806,845 10.07.06 US

Filing date 10 July 2007

Wipo publication date 17 January 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/007072 Priority application(s): WO2008/007072

2 April 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Methods for cancer treatment using TAK1 inhibitors

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007274056-Method for introducing siRNA into cells by photochemical internalisation

2007274054-Benzodiazepine salts